title: [Review and revision of guidelines for ovarian cancer treatment in Japan].
abstract: A survey of members of the Japan Society of Gynecologic Oncology revealed that 93% of the members use the present Guideline for Ovarian Cancer Treatment in practice. There is an international consensus about first-line treatment for ovarian cancer. In contrast, the treatment for sex-cord stromal tumor, which is rare, and recurrent cancer are not standardized. In addition, management for borderline malignant tumor has been controversial. The new revision incorporates a new chapter regarding these matters. The revised Guideline may be more useful. We hope that re-examination and future revisions will be made to continually update the Guideline.
authors.affiliation: Derpartment of Gynecologic Oncology, Tottori University, 36-1 Nishimachi, Yonago, Japan.
authors.forename: Junzo
authors.initials: J
authors.lastname: Kigawa
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Katabuchi
authors.forename: Nobuo
authors.initials: N
authors.lastname: Yaegashi
mesh_terms: D005260:Female; D006801:Humans; D007564:Japan; D010051:Ovarian Neoplasms / Q000473:pathology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012008:Recurrence; D011795:Surveys and Questionnaires